(CLMT) Calumet Specialty Products - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1314761032
CLMT EPS (Earnings per Share)
CLMT Revenue
CLMT: Specialty Chemicals, Renewable Fuels, Performance Lubricants
Calumet Specialty Products Partners is a diversified energy company that produces a wide range of specialty products and renewable fuels, catering to various consumer-facing and industrial markets across North America and globally. The companys business is segmented into Specialty Products and Solutions, Montana/Renewables, and Performance Brands, each offering distinct products such as customized lubricating oils, renewable diesel, and high-performance branded products.
The Specialty Products and Solutions segment is a key player in the production of various solvents, waxes, and other specialty chemicals, while the Montana/Renewables segment is focused on processing renewable feedstocks into sustainable aviation fuel, renewable hydrogen, and other eco-friendly products, alongside conventional gasoline and diesel production. Meanwhile, the Performance Brands segment leverages brands like Royal Purple, Bel-Ray, and TruFuel to market high-performance products to wholesale distributors and retail chains.
With a rich history dating back to 1919 and headquartered in Indianapolis, Indiana, Calumet has established itself as a significant entity in the Oil & Gas Refining & Marketing sub-industry. The companys commitment to producing a diversified slate of products positions it for potential growth in an evolving energy landscape.
Analyzing the technical data, CLMTs current price is $16.86, with its SMA20 and SMA50 indicating a positive trend. The stock is above its 50-day moving average but slightly below its 200-day moving average, suggesting a potential for stabilization. The ATR indicates a moderate volatility of 4.25%. Given the current fundamental data, including a market cap of $1.164 billion and a forward P/E ratio of 11.35, alongside a high RoE of 48.58%, the company appears to be undervalued. A forecast based on these indicators suggests that CLMT may experience a positive trajectory, potentially reaching $20 in the near term, driven by its diversified product slate, improving renewable energy focus, and current undervaluation.
To capitalize on this potential, investors should closely monitor CLMTs ability to maintain its current production levels, expand its renewable energy portfolio, and effectively manage its costs. A break above the 52-week high of $23.58 could signal significant upside potential. Conversely, failure to maintain the current price levels could indicate a revisit of the $8.99 low. Thus, a balanced view considering both technical and fundamental analysis is crucial for making informed investment decisions regarding CLMT.
Additional Sources for CLMT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CLMT Stock Overview
Market Cap in USD | 1,373m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Oil & Gas Refining & Marketing |
IPO / Inception | 2006-01-26 |
CLMT Stock Ratings
Growth Rating | 57.1 |
Fundamental | -16.7 |
Dividend Rating | 11.7 |
Rel. Strength | 1.68 |
Analysts | 3.86 of 5 |
Fair Price Momentum | 17.77 USD |
Fair Price DCF | - |
CLMT Dividends
Currently no dividends paidCLMT Growth Ratios
Growth Correlation 3m | 86.7% |
Growth Correlation 12m | -41.3% |
Growth Correlation 5y | 68.8% |
CAGR 5y | 49.26% |
CAGR/Max DD 5y | 0.80 |
Sharpe Ratio 12m | -0.06 |
Alpha | -25.27 |
Beta | 1.790 |
Volatility | 51.68% |
Current Volume | 1061.3k |
Average Volume 20d | 797.2k |
As of July 01, 2025, the stock is trading at USD 15.76 with a total of 1,061,289 shares traded.
Over the past week, the price has changed by -0.60%, over one month by +18.01%, over three months by +24.25% and over the past year by -2.32%.
Neither. Based on ValueRay´s Fundamental Analyses, Calumet Specialty Products is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.71 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLMT is around 17.77 USD . This means that CLMT is currently undervalued and has a potential upside of +12.75% (Margin of Safety).
Calumet Specialty Products has received a consensus analysts rating of 3.86. Therefor, it is recommend to buy CLMT.
- Strong Buy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CLMT Calumet Specialty Products will be worth about 20 in July 2026. The stock is currently trading at 15.76. This means that the stock has a potential upside of +26.78%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 19 | 20.6% |
Analysts Target Price | 19 | 20.6% |
ValueRay Target Price | 20 | 26.8% |